Skip to content
AnalystLens

Insmed 8-K Report, Corporate Update (Aug 9, 2024)

Reports
Other Events
Filing Date
Filed August 9, 2024
Period End
August 9, 2024
Security
INSM
In the record · 2016–202610-K1110-Q338-K134

INSM filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 134 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jan ’18Jan ’18
  2. Leadership change8-K · May ’20May ’20
  3. Material agreement8-K · Oct ’22Oct ’22
  4. Leadership change8-K · Oct ’26Oct ’26

01—Abstract

Summary

Summary of the 8-K filed August 9, 2024. Cited figures are marked; the original filing is the authoritative source.

Insmed Incorporated (INSM) filed this Current Report on Form 8-K to report that on August 9, 2024 (the "Redemption Date"), it completed the previously announced redemption of all outstanding aggregate principal of its 1.75%a Convertible Senior Notes due 2025 (the "Notes").

Notes with an aggregate principal amount of $198,000b that had not already been converted by holders were redeemed for cash. The Notes were redeemed at 100% of their principal amount, plus accrued and unpaid interest up to, but excluding, the Redemption Date. The redemption was carried out under the Indenture dated January 26, 2018, as supplemented by the First Supplemental Indenture of the same date, between the Company and Computershare Trust Company, National Association, as successor trustee to Wells Fargo Bank, National Association.

For investors, this is a routine debt-settlement event. The filing reports only the small residual principal that remained after prior conversions, and it contains no new financial results, guidance, or changes to operations.

02—Key points

Key Highlights

  1. Insmed completed the redemption of its 1.75% Convertible Senior Notes due 2025 on August 9, 2024.
  2. Notes with an aggregate principal amount of $198,000 that had not been converted were redeemed for cash.
  3. Redemption price was 100% of principal amount, plus accrued and unpaid interest to, but excluding, the Redemption Date.
  4. The redemption was made under the January 26, 2018 Indenture and First Supplemental Indenture with Computershare Trust Company, National Association, as successor trustee to Wells Fargo Bank, National Association.
  5. The filing is limited to a Item 8.01 (Other Events) disclosure and includes no new financial results or guidance.

03—Questions

Frequently Asked Questions

  1. How much of the convertible notes remained outstanding before redemption?

    Notes with an aggregate principal amount of $198,000 that had not already been converted by holders were redeemed on August 9, 2024.

  2. What price did holders receive for the redeemed notes?

    Holders received cash equal to 100% of the principal amount of the Notes, plus accrued and unpaid interest to, but excluding, the Redemption Date.

  3. Does this redemption affect Insmed's operations or guidance?

    The filing reports only the completion of the note redemption under Item 8.01 (Other Events). It does not discuss operating results, financial guidance, or other business developments.

  4. Under which governing agreement was the redemption made?

    The redemption was effected under the Indenture dated January 26, 2018, as supplemented by the First Supplemental Indenture of the same date, between the Company and Computershare Trust Company, National Association, as successor trustee to Wells Fargo Bank, National Association.

04—Continue

← View all 8-K filings